首页> 外国专利> MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Application to the stimulation of CTL and vaccination in vivo; analysis of vaccinating composition in vitro

MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Application to the stimulation of CTL and vaccination in vivo; analysis of vaccinating composition in vitro

机译:MHC-I限制了HIV-1病毒体抗原的呈递,而没有病毒复制。应用于体内CTL刺激和疫苗接种;疫苗接种成分的体外分析

摘要

Dendritic cells and macrophages can process extracellular antigens for presentation by MHC-I molecules. HIV-1 epitopes derived from incoming virions are presented through the exogenous MHC-I pathway in primary human dendritic cells, and to a lower extent in macrophages, leading to cytotoxic T lymphocyte activation in the absence of viral protein neosynthesis. Exogenous antigen presentation required adequate virus-receptor interactions and fusion of viral and cellular membranes. These results provide new insights about how anti-HIV cytotoxic T lymphocytes can be activated and are useful for anti-HIV vaccine design.
机译:树突状细胞和巨噬细胞可以加工细胞外抗原,以通过MHC-1分子呈递。来源于传入病毒体的HIV-1表位通过外源性MHC-1途径呈递给原代人树突状细胞,但在巨噬细胞中呈较低程度,从而导致在没有病毒蛋白新合成的情况下激活细胞毒性T淋巴细胞。外源抗原呈递需要足够的病毒-受体相互作用以及病毒和细胞膜融合。这些结果提供了有关如何激活抗HIV细胞毒性T淋巴细胞的新见解,可用于抗HIV疫苗设计。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号